DMAC logo

DMACDiaMedica Therapeutics Inc

$5.64
$0.20
(3.42%)
Today
Closed $5.64
$0.00
(0.00%)
After Hours
Updated: 04:15 PM EDT
EarningsAug 11
Mkt Cap$314.68M
Vol195,882.00

About

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
35

Frequently Asked Questions

What is Market Cap of DiaMedica Therapeutics Inc?
What is the 52-week high for DiaMedica Therapeutics Inc?
What is the 52-week low for DiaMedica Therapeutics Inc?
What is DiaMedica Therapeutics Inc stock price today?
What was DiaMedica Therapeutics Inc stock price yesterday?
What is the PE ratio of DiaMedica Therapeutics Inc?
What is the Price-to-Book ratio of DiaMedica Therapeutics Inc?
What is the 50-day moving average of DiaMedica Therapeutics Inc?
How many employees does DiaMedica Therapeutics Inc have?

Advertisement|Remove ads.